Skip to content
Menu

NeuroSense Therapeutics FY EPS $(0.44) Misses $(0.35) Estimate

Benzinga Newsdesk 7 months ago

EarningsEarnings MissesNews

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

NeuroSense Therapeutics (NASDAQ:NRSN) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.35) by 25.71 percent.

NeuroSense Therapeutics (NASDAQ:NRSN) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.35) by 25.71 percent.

Read at benzinga.com